These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Towards newer molecular targets for chronic diabetic complications. Khan ZA; Farhangkhoee H; Chakrabarti S Curr Vasc Pharmacol; 2006 Jan; 4(1):45-57. PubMed ID: 16472176 [TBL] [Abstract][Full Text] [Related]
7. Lead Optimization Resources in Drug Discovery for Diabetes. Tiwari P; Katyal A; Khan MF; Ashraf GM; Ahmad K Endocr Metab Immune Disord Drug Targets; 2019; 19(6):754-774. PubMed ID: 30834844 [TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and diabetes mellitus. Yang H; Jin X; Kei Lam CW; Yan SK Clin Chem Lab Med; 2011 Nov; 49(11):1773-82. PubMed ID: 21810068 [TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem Cells. Kawser Hossain M; Abdal Dayem A; Han J; Kumar Saha S; Yang GM; Choi HY; Cho SG Int J Mol Sci; 2016 Feb; 17(2):256. PubMed ID: 26907255 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease. Cooper GJ Drugs; 2011 Jul; 71(10):1281-320. PubMed ID: 21770477 [TBL] [Abstract][Full Text] [Related]
12. Delivery aspects of antioxidants in diabetes management. Duvvuri LS; Katiyar S; Kumar A; Khan W Expert Opin Drug Deliv; 2015 May; 12(5):827-44. PubMed ID: 25582375 [TBL] [Abstract][Full Text] [Related]
13. Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus. Endemann DH; Schiffrin EL Curr Hypertens Rep; 2004 Apr; 6(2):85-9. PubMed ID: 15010009 [TBL] [Abstract][Full Text] [Related]
14. Emerging applications of metabolomics in drug discovery and precision medicine. Wishart DS Nat Rev Drug Discov; 2016 Jul; 15(7):473-84. PubMed ID: 26965202 [TBL] [Abstract][Full Text] [Related]
15. The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review. Antwi F; Fazylova N; Garcon MC; Lopez L; Rubiano R; Slyer JT JBI Libr Syst Rev; 2012; 10(42 Suppl):1-14. PubMed ID: 27820152 [TBL] [Abstract][Full Text] [Related]
16. Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR. Maiese K Neural Regen Res; 2016 Mar; 11(3):372-85. PubMed ID: 27127460 [TBL] [Abstract][Full Text] [Related]
17. Drug-induced changes in risk/biomarkers and their relationship with renal and cardiovascular long-term outcome in patients with diabetes. Miao Y; Smink PA; de Zeeuw D; Lambers Heerspink HJ Clin Chem; 2011 Feb; 57(2):186-95. PubMed ID: 21159899 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms behind the anti-inflammatory actions of insulin. Hyun E; Ramachandran R; Hollenberg MD; Vergnolle N Crit Rev Immunol; 2011; 31(4):307-40. PubMed ID: 21899513 [TBL] [Abstract][Full Text] [Related]
19. Approaches to prevention of cardiovascular complications and events in diabetes mellitus. Coccheri S Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145 [TBL] [Abstract][Full Text] [Related]
20. The TZD insulin sensitizer clue provides a new route into diabetes drug discovery. Colca JR Expert Opin Drug Discov; 2015 Dec; 10(12):1259-70. PubMed ID: 26479699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]